Gbola Amusa ( 10 of 10 )
The ones that are lost will probably be lost for good.
The ones that are lost will probably be lost for good.
It's wide open, ... The obesity market is unique in that it is probably the largest market in the world. read more
It's wide open, ... The obesity market is unique in that it is probably the largest market in the world. However, nothing really works well in terms of safety and tolerability.
It's a drop in the bucket. It's helping the stock price today, but gastric cancer is not one of the read more
It's a drop in the bucket. It's helping the stock price today, but gastric cancer is not one of the biggest markets for cancer.
These are high-risk, high-reward [vaccines]. The chances of their success are remote, but if they do work, we would expect read more
These are high-risk, high-reward [vaccines]. The chances of their success are remote, but if they do work, we would expect them to be blockbusters if they produced enough to supply developed nations and undeveloped nations.
[The market] is under-performing in terms of sales because it's tough to find something that works.
[The market] is under-performing in terms of sales because it's tough to find something that works.
This drug has a very high likelihood of success.
This drug has a very high likelihood of success.
It's very costly for Americans to continue to fatten up.
It's very costly for Americans to continue to fatten up.
It brings attention back to a lot of the risks in pharmaceuticals right now with regards to drug safety.
It brings attention back to a lot of the risks in pharmaceuticals right now with regards to drug safety.
It left us with a flawed system where they try to get there first and they challenge patents even if read more
It left us with a flawed system where they try to get there first and they challenge patents even if they feel they're not going to win. The system is broken.
From an R&D perspective, they've actually got the first or second largest cancer pipeline in the world. So, they're moving read more
From an R&D perspective, they've actually got the first or second largest cancer pipeline in the world. So, they're moving in the right direction.